metronidazole 1% gel
Sponsors
Galderma R&D
Conditions
Skin Manifestations
Phase 4
Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin
CompletedNCT01139008
Start: 2010-06-30End: 2010-06-30Updated: 2022-08-01
Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin
CompletedNCT01139047
Start: 2010-06-30End: 2010-06-30Updated: 2022-08-01